News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
The Cardano Foundation calls on the EU not to extend MiCA to DeFi and staking.
CoinWorld news, according to Cointelegraph, the Cardano Foundation has called on the EU not to extend the Markets in Crypto-Assets Regulation (MiCA) to decentralized finance (DeFi) and staking, urging that relevant rules be based on financial risk rather than technology.
U.S. Department of State: Ordered the departure of non-emergency U.S. government employees and their family members in Saudi Arabia only.
CoinWorld news, U.S. Department of State: The U.S. Department of State has ordered the departure of non-emergency U.S. government employees and their family members in Saudi Arabia only.
The SOL large holder account long/short ratio is 2.592.
CoinWorld data: The latest 4-hour snapshot for SOLUSDT shows that among the top 20% of accounts by margin balance, the long-short account ratio is 2.592, with more net long accounts among large holders. Compared with the same-metric snapshot 24 hours ago, it is down 0.2365; compared with the same-metric snapshot 7 days ago, it is down 0.2409.
Coinbase launches perpetual futures trading feature for AI agents
Coinbase announced on X that it has launched perpetual futures trading functionality for AI agents, naming it "aifi²".
nscale CEO: Contract value has doubled since March.
CoinWorld news, the nscale CEO said that since the March funding round, the AI cloud company's contract value has doubled. The CEO told employees that nscale is facing investor opposition to its IPO valuation target.
Meta Platforms(META.O)涨幅迅速收窄至0.85%
CoinWorld news: Meta Platforms (META.O) quickly narrowed its gain to 0.85%, after having risen as much as 2.71% earlier.
Analyst: Meta Platforms may announce non-voting stock plan on Wednesday.
According to a report by the U.S. financial news outlet Semafor, Meta Platforms (META.O) may officially announce a non-voting share plan as early as Wednesday alongside its quarterly earnings release, aimed at financing AI investments. The move will not dilute Zuckerberg's control.
Meta plans to issue new non-voting shares to support AI buildout.
CoinWorld news, according to The Wall Street Journal, Meta ($META) plans to create a new class of non-voting shares, aiming to allow the company to sell new shares to fund its AI buildout without weakening Mark Zuckerberg's control. The plan may be announced in Wednesday's earnings report.
ETH large holder account long/short ratio is 1.624
CoinWorld data: The latest 4-hour snapshot for ETHUSDT shows that among the top 20% of accounts by margin balance, the long-short account ratio is 1.624, with more net long accounts among large holders. Compared with the same-metric snapshot 24 hours ago, it is down 0.5366; compared with the same-metric snapshot 7 days ago, it is down 0.751.